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Abstract
Cardiac experimental electrophysiology is in need of a well-defined Minimum Information 
Standard for recording, annotating, and reporting experimental data. As a step toward establishing 
this, we present a draft standard, called Minimum Information about a Cardiac Electrophysiology 
Experiment (MICEE). The ultimate goal is to develop a useful tool for cardiac electrophysiologists 
which facilitates and improves dissemination of the minimum information necessary for 
reproduction of cardiac electrophysiology research, allowing for easier comparison and utilisation 
of findings by others. It is hoped that this will enhance the integration of individual results into 
experimental, computational, and conceptual models. In its present form, this draft is intended for 
assessment and development by the research community. We invite the reader to join this effort, 
and, if deemed productive, implement the Minimum Information about a Cardiac 
Electrophysiology Experiment standard in their own work.
Keywords
Minimum Information Standard; Cardiac Electrophysiology; Data Sharing; Reproducibility; 
Integration; Computational Modelling
INTRODUCTION
Here, we present a draft Minimum Information Standard for recording, annotating, and 
reporting experimental cardiac electrophysiology data, which we are calling the Minimum 
Information about a Cardiac Electrophysiology Experiment (MICEE) standard. The concept 
is that for relevant studies, this information will be made available in an online repository 
and referenced in any related publications. Our hope is that this reporting standard will 
develop into a tool used by the experimental cardiac electrophysiology community to 
facilitate and improve recording and dissemination of the minimum information necessary 
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for reproduction of cardiac electrophysiology experimental research, via contextualisation to 
allow for easier comparison and usage of findings by others, and to enhance the integration 
of results into other experimental, computational, and conceptual models.
Throughout the scientific community, there is growing recognition that open-access data-
sharing promotes research transparency, assessment and validation of experimental data, and 
design of new experiments, furthering discovery from past work and the development of 
broader computational and/or conceptual models that are based firmly on experimental 
insight (Smith and Noble, 2008). This is reflected by the current requirements of some 
funding agencies and journals for data sharing, as well as the concerted efforts of various 
institutions in its promotion and implementation (Cragin et al., 2010; Nelson, 2009). While 
there are examples of very useful data sharing resources, such as the database of Genotypes 
and Phenotypes (dbGAP; http://www.ncbi.nlm.nih.gov/gap/) for storing genome-wide 
association study data, or the Gene Expression Omnibus (GEO; http://
www.ncbi.nlm.nih.gov/geo/) for mRNA data, many real and perceived barriers need to be 
overcome before such resources can achieve their full potential. These include reluctance to 
contribute community data that has taken years to collect, concerns about data misuse and/or 
misattribution, worries about intellectual property rights associated with data, and the 
additional time, effort, and resources required to make data and their contextualisation via 
meta-data accessible by others (Cragin et al., 2010; Nelson, 2009). An additional 
fundamental problem is a lack of clear and useful reporting standards and associated 
infrastructure. Minimum Information Standards and reporting guidelines are now recognized 
as an important step towards establishing effective data use and re-use, thus optimising data 
utilisation and enabling experimental reproducibility – something that is already an explicit 
requirement for the scientific research and communication process.
Any useful set of reporting standards is necessarily discipline-specific, describing what raw- 
and meta-data should be made available, and how this should be formatted for general use, 
so that necessary and sufficient information is provided to allow reproduction of 
experimental interventions and study procedures. While this is critical for well-informed 
evaluation of results and conclusions, the associated overhead should remain minimal, to 
encourage compliance (Taylor et al., 2007). The identification of a minimally necessary and 
sufficient set of parameters is a difficult task, confounded by the overwhelming diversity of 
scientific practices and information in any given field.
In recent years, there has been a growing interest in identifying formalised reporting 
requirements for experimental and computational research. Current efforts are being brought 
together under the Minimum Information about a Biomedical or Biological Investigation 
(MIBBI) umbrella (http://www.mibbi.org/), aimed at uniting the various communities 
developing Minimum Information Standards for the description of data sets and the 
workflows by which they were generated (Kettner et al., 2010; Taylor et al., 2008). 
Currently, however, no set of reporting standards exist for cardiac electrophysiology 
experimentation, contributing to a lack of consistency in the information reported upon 
publication. This has resulted from neither negligence nor ill intent. Constraints on time and 
resources, as well as outlet-specific content and formatting demands, make the task of 
reporting in a standardised fashion appear burdensome and (possibly) not worth the extra 
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effort. One might regard it as ironic, that the current mode may in fact be a larger drain on 
time and resources for the community overall, than the alternative. To reproduce 
experiments from published methods sections in the literature is, by and large, not possible 
without in-depth knowledge of all materials, procedures, and interventions (which will be 
rare in fields with a low proportion of ‘routine’ research activities). This situation has been 
made worse by the progressive reduction in space allocated to the description of methods in 
many journals (in some cases this has been partly remedied by online supplemental 
information, although standardisation of such sections might still aid experimental 
reproducibility). Lack of reporting standards also makes it particularly difficult to enable 
data utilisation across fields, such as by computational modellers who may be less familiar 
with determinants of experimental studies that are ‘at the fringes’ of experimental design 
(while pH or ambient temperature may be obvious parameters to watch out for, osmotic 
pressure of solutions or the supplier of a transgenic strain may feature less prominently on 
the list of possible confounding aspects). Furthermore, ‘negative’ results, i.e., the finding 
that a particular intervention does not give rise to a hypothesised response, are published far 
too rarely (even though the only thing ‘negative’ about these data are that they do not reach 
the public domain), such that positive results, even when scarce, may dominate perception. 
This results in an abundance of inadvertently repeated experiments and a profound 
publication bias that hampers scientific understanding (Schooler, 2011), although there are 
current efforts to correct this (such as with the Journal of Negative Results in Biomedicine; 
http://www.jnrbm.com/).
Thus, standardised reporting guidelines may help to ensure availability of the information 
needed to reproduce a study, or to not attempt it, avoiding wasted time and resources, which 
increases overall productivity. Additionally, increased emphasis on the integration of insight 
from different levels of structural complexity (Kohl et al., 2010), and a renewed focus on the 
translation of information learned through basic science to the clinic, requires more stringent 
control and documentation of experimental conditions and protocols (especially important in 
the post-genomic era, with the increasingly common use of small animal models to mimic 
human conditions and to explore treatment possibilities). Careful consideration should be 
paid to what are seemingly inevitable experimental restrictions, such as caused by sub-
optimal experimental design, systematic experimental error, and parameter variations 
outside the control of the experimentalist. This will also benefit efforts to conduct 
quantitative analysis and computational modelling, by facilitating inclusion of important 
parameters that potentially influence results, such as factors accounting for subject specific 
differences (e.g., age and sex). While one cannot predict all of the information that might be 
necessary for post hoc computational and/or conceptual ‘modelling’ - especially with the 
rapid evolution of this field - having reported what is currently understood to constitute the 
most important factors contributing to an experimental outcome will be of significant utility 
for the identification and validation of novel hypotheses (Greenstein and Winslow, 2011; 
Rudy, 2000).
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PROPOSED DRAFT OF A MINIMUM INFORMATION STANDARD FOR 
CARDIAC ELECTROPHYSIOLOGY EXPERIMENTATION
The goal of this paper is to present a draft of a Minimum Information Standard for cardiac 
electrophysiology experimentation. This has been modelled after the Minimum Information 
about a Neuroscience Investigation (MINI; http://www.carmen.org.uk/standards) standard 
(Gibson et al., 2009), but tailored for the specific needs of cardiac electrophysiology. It 
contains a draft of what is believed to be an explicit minimum set of information that is 
necessary for reproduction of experimental cardiac electrophysiology research and its 
integration into other experimental or computational models, while hopefully remaining 
general enough to cover a majority of cases in the field. A significant proportion of this 
information would normally already appear in the Methods sections of publications. 
Nonetheless, it has been included here, as having all information in one place will improve 
efficiency of access. The MICEE standard has been organised into the following five 
sections, which are believed to encapsulate the most important aspects of the majority of 
cardiac electrophysiology experiments:
1. Material
2. Environment
3. Protocols
4. Recordings
5. Analysis
Below we describe the rationale for these sections, and the general information essential to 
each of them, in order to clarify the content of the proposed draft reporting standard, and to 
aid broader discussion and further development of the proposal. The complete MICEE draft 
standard can be found in Appendix A. The described reporting standard is ‘a draft 
sequence’, and very much open to further development in the light of community needs and 
preferences. We do not specifically discuss each individual element, but hope that all 
elements follow from the principles discussed above. Finally, to illustrate the utility of the 
MICEE standard, an example (using a study recently published by some of the authors (Iribe 
et al., 2009)) is given in Appendix B, which highlights the need for information not 
contained in ‘the usual’ Methods section.
1. Material
This section gives details of the subject(s) under investigation. Depending on the nature of 
the study, the type(s) may be human, whole animal, isolated heart, isolated or engineered 
tissue, isolated, cultured, or stem cells, or cell fragments (e.g., membrane patches), and 
subheadings are provided for each. Each of these subheadings has its own specific 
characteristics, relating to features that are increasingly recognized as important to cardiac 
electrophysiology (e.g., sex, developmental stage, genetic variation, disease background, and 
husbandry, including diet, environmental enrichment, and light cycle). Additionally, it 
includes information about sample preparation and maintenance, focusing on aspects such as 
method of animal dispatch, anatomical origin of the sample, isolation procedure, cell 
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selection process, and growth, culture, and differentiating conditions. This information is 
essential to the outcome of cardiac electrophysiology studies, as it is arguably one of the 
most important acute determinants of the quality, viability, and reproducibility of 
experimental model systems.
2. Environment
Information contained in this section, relating to environmental conditions in which an 
experiment is conducted, is also vital to the interpretation and comparison of cardiac 
electrophysiology results, but is often not well-controlled or monitored (e.g., ‘room 
temperature’), with specific details underreported in publications (and perhaps increasingly 
so, which would be a worrying trend). Included factors range from sample temperature (e.g., 
temperature at the site of experimentation, not in a fluid reservoir for example) and solution 
characteristics, to flow rates, bath volume, and details about the presence of chemicals, dyes, 
gases, or drugs. This not only makes information available for later study verification, but 
also highlights the importance of a range of parameters for experimental control, potentially 
encouraging closer monitoring of relevant conditions, where possible.
3. Protocols
This heading provides a description of the experimental protocols of a study. Including 
detailed descriptions of experimental procedures is becoming progressively more important, 
as an increasing number of journals are either reducing the space provided for publishing 
this information (often due to economical and citation-impact related pressures), or 
relegating it to electronic add-on resources. It is by necessity less specific than other 
sections, requiring a sufficiently detailed account of procedures and interventions, as cardiac 
electrophysiology draws on an extremely wide array of experimental techniques and model 
systems, often with laboratories following their own individually-tailored protocols. Also, 
this is the area where scientific originality is, perhaps, the most important driver of progress. 
As such, the prescription of a firm reporting standard for information of this type is neither 
possible nor desirable.
4. Recordings
This section addresses the specifics of equipment and software used to record and pre-
process signals in an experiment, including relevant parameters of operation. The 
importance of this information may not be as self-evident as other aspects described above, 
which may result in severe under-reporting in publications. This includes features such as 
detailed description of timing control, data sampling rates, filtering and smoothing, bit 
depth, gain, and dynamic range, all of which can greatly affect the nature and information 
content of data. For example, with patch-clamp recordings, technical aspects are essential 
for appropriate application of the technique and errors in factors such as series resistance 
and voltage-clamp control can lead to errors in the basic properties of currents, resulting in 
misinterpretation of results and misleading conclusions.
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5. Analysis
This part of the reporting standard provides information on the software and methods used in 
data processing to extract information, including details of post hoc filtering, normalisation, 
interpolation, inclusion/exclusion criteria, n number(s), and statistical methods. Its 
importance is fairly clear, as outcomes can be significantly altered by data manipulation, but 
still, detail provided in publications tends to be insufficient for adequate reproduction. An 
additional feature of this section is the inclusion of example(s) of raw and processed data 
(from the same recording), which will allow others to assess whether they are able to 
replicate described approaches (and which is also often omitted from publications).
IMPLEMENTING AND DEVELOPING THE MICEE STANDARD
It is important to repeat that this reporting standard is meant, in its present form, as a place 
to start. The set of minimum information must develop from experience and input from the 
greater community, which may include both growth and reduction of currently envisaged 
categories and parameters. The hope is that, with time, adherence to minimum reporting 
standards will become second nature, as is the current expectation that the composition of 
solutions and their pH form part of any methods section in this field. This would help to 
address some of the challenges associated with data sharing, experimental reproducibility, 
model interrelation, and correlation of experimental and computational studies in cardiac 
electrophysiology research. The concept is also that the MICEE repository, discussed below, 
will allow for dissemination of unpublished (and thus less publically available) results, such 
as those described in PhD theses and unreported ‘negative’ findings. This may avoid 
repetition of experiments and improve scientific understanding, and when pertinent, can be 
cited in future publications.
Progress could be facilitated by a research program to catalogue past work (similar to what 
has been done for a single recent study in Appendix B). Such shared access to 
‘retrospective’ communications has been developed, with significant success, for 
computational cardiac electrophysiology models, which is benefiting from the increasing use 
of a standardised format for communication and modelling (Nickerson and Buist, 2009), 
called Cell Markup Language (CellML) (Cuellar et al., 2003). The CellML model repository 
now contains over 250 cardiac electrophysiology cell models (see http://models.cellml.org/
electrophysiology/), curated and tested to different levels, making models and associated 
meta-data (like original publications) easily accessible.
Once the reporting standard begins to converge, it will be important to incorporate it into the 
MIBBI framework (see http://www.mibbi.org/index.php/Projects/MICEE) and to work with 
other communities to explore standardized nomenclatures and combined workflow elements, 
to avoid double work and incompatibility of outputs. For instance, the Virtual Physiological 
Human (VPH) (Fenner et al., 2008; Hunter et al., 2010; Hunter and Viceconti, 2009; Kohl 
and Noble, 2009) and Physiome (Bassingthwaighte et al., 2009; Bassingthwaighte, 1997; 
Hunter et al., 2002; Smith et al., 2009) projects are promoting the development of model and 
data encoding standards for the computational modelling community, along with their 
associated minimum information requirements. Efforts are also underway to establish 
uniform data standards for clinical cardiovascular electrophysiology studies and procedures, 
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to serve as a basis for research and practice databases (Buxton et al., 2006; Weintraub et al., 
2011). It will be essential to promote compatibility with these activities, especially for use of 
experimental data in computational model building and validation. Additionally, it could 
prove helpful if the formal reporting standard – once endorsed more broadly by the 
community – would be adopted by one or more professional societies. Equally crucial will 
be the question whether leading journals in the field may be convinced to identify ‘MICEE-
compatible data reporting’ as a desirable approach.
Most importantly, beyond the desire to increase awareness of the need for Minimum 
Information Standards in cardiac electrophysiology experimentation, we intend to initiate 
action. Thus, the authors of this communication are making a commitment to adhere to the 
proposed reporting standard for a twelve-month period, starting at the beginning of 2012, by 
recording the then identified MICEE information for all of their relevant studies. Upon study 
completion, this information will be made available in a repository maintained by the Johns 
Hopkins University CardioVascular Research Grid (accessible at http://www.micee.org/). 
When relevant, MICEE entries will link-out to the digital object identifiers (DOI) of 
publications, and be referenced in the related papers with a citable identification. This test of 
utility will help in assessing and shaping the MICEE approach, and we invite others in the 
community to join us in this effort. We also request feedback on how the reporting standard 
might be improved, which will be possible via a public notice board on the MICEE.org 
website, to facilitate community discussion. Finally, once the standard begins to gain 
broader acceptance by cardiac electrophysiologists, an oversight committee will be 
established to manage the process of standard refinement and future extensions of MICEE.
PRESENT DIFFICULTIES AND CHALLENGES AHEAD
Even amongst those who believe Minimum Information Standards are necessary and 
important, a common argument against their development is that “it is a nearly impossible 
task”. Other valid criticisms include the concern that their implementation is associated with 
too much work, or – conversely – that they do not go far enough. However, if one regards the 
status quo as not ideal, it is hard to argue that useful progress could not be made. It is 
obvious that emergence of a complete consensus by a research community on any reporting 
standard is highly unlikely. This applies to the proposed MICEE standard, and it includes the 
authors of this paper. There is, however, agreement amongst the authors that there is a need 
to agree on, and define (standardise) the minimum information needs for cardiac 
electrophysiology experimentation. We realise that a complete description of any experiment 
is unachievable, but believe that the proposed standard encompasses key features necessary 
for the effective use of information by other researchers. Besides, ‘exact’ repetition of an 
experiment with identical conditions, even by the original experimentalist, is in itself 
improbable (and not usually warranted or desired). Proper documentation of the factors that 
may be most important to experimental outcomes, however, is an attainable and relevant 
goal.
It is clear that convergence to an agreement on a ‘final’ MICEE standard will need time, but 
once a standard has been accepted, the question remains as to the best ways of encouraging 
‘compliance’. As with most change, a combination of ‘stick and carrot’ tends to be most 
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productive. Wielding the stick, one could imagine an approach where those who have the 
authority demand compliance. Examples would include funding agencies (which can make it 
a condition of support), scientific societies (which can establish it as a precedent), and 
journals (which can make it part of publication policies, or simply formalise their methods 
sections and online supplements to provide information congruent to the proposed standard). 
By and large, it seems that scientists generally do not respond well to (new) dogmas and 
demands, as even widely accepted (and exceedingly valuable) precedents, for instance the 
système international d’unités (SI), have had (and still have) a hard time to penetrate certain 
traditional barriers. Ultimately, the key question is: “what is in it for me?”. If and when a 
new tool (e.g., a reporting standard) proves to be productive and has clear value, for example 
saving time, effort, and resources, it turns itself into the ‘carrot’. A useful example of this is 
the now widely-accepted standardisation approach in the Systems Biology field, the Systems 
Biology Markup Language (SBML) (Hucka et al., 2003).
The trick, then, will be to develop MICEE to a level where it becomes a tool of utility. 
Therefore, the MICEE standard is a form of self-regulation, shaped by the greater 
community, such that the final product will be formed by end-users, with the aim of making 
it a useful time saving measure, rather than a hindrance. In this context, the goal is also for it 
to be useful for researchers in creating ‘internal’ meta-data collections for continued work, 
sharing among collaborators, and eventual publication. This will be additionally important 
for its effectiveness as a time saving device, as collection of data at-the-time-of-study will 
facilitate its later dissemination. For this, a scientist controlled embargo system will be 
essential (Cragin et al., 2010), and emulating the functionality of existing ‘staging 
repository’ tools, such as the Data Staging Repository (DataStar; http://
datastar.mannlib.cornell.edu/), may be a constructive approach.
Attitudes towards reporting standards and their implementation are changing in many other 
areas of bioscience research, spearheaded by an active and organised minimum information 
community: the MIBBI portal currently lists 32 Minimum Information Standards (see http://
www.mibbi.org/index.php/MIBBI_portal). Common to those reporting standards that have 
been successful is the availability of technical support, in the form of software for formatting 
experimental data and recording associated meta-data and repositories for deposition, 
storage, and retrieval of this information, including software and user-interfaces for efficient 
database searches and data exportation (with links to publications and cross-links to other 
experiments and sources of information). In general, there are three necessary elements for 
reporting standard utilisation: (i) definition of the Minimum Information Standard, (ii) a 
syntax for expression of data, and (iii) a meta-data standard for semantics (via ontologies to 
ensure the use of accepted terminology). Our aim, at this point, is to propose and develop (i). 
In the near future, this will need to be followed by (ii) and (iii), to ensure efficient automated 
search processes. For this, an XML-based standard for time varying data will be useful, such 
as is being developed through the BioSignal Markup Language (BioSignalML) (Brooks, 
2009). Ultimately, further development will require a commitment from national, regional, 
and/or private funding agencies, and while resources are always in short supply, cost-benefit 
considerations suggest that this would be in the best interest of all involved.
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As always, it is helpful to try to learn from the experience of previous minimum information 
efforts. The pioneering, and maybe most successful, example of a reporting standard was 
published 10 years ago, the Minimum Information About a Microarray Experiment 
(MIAME) standard (Brazma et al., 2001). The assertion at the time was that, to make data 
usable for analysis, everything relevant had to be recorded systematically (Brazma, 2009). 
Perhaps most important to its success was the fact that a majority of scientific journals made 
submission of MIAME-compliant data to public repositories mandatory. Also essential was 
its intuitive interface, where users could place queries to search databases. The relevant 
databases (for instance dbGAP), curate, analyse, and transform microarray data, making it 
widely accessible. However, even with the general adoption of MIAME principles, it can be 
difficult to obtain desired microarray data (Ioannidis et al., 2009), which has been attributed 
mainly to the fact that the initial lack of a standard computer-readable formats for 
representing information has limited its utility (Brazma, 2009). This has been improved by 
specification of formats by the Functional Genomics Data (FGED) Society (http://
www.mged.org/, which was founded in 1999 as the Microarray Gene Expression Data 
(MGED) Society). Another lesson has been that it is important to allow ‘inheritance’ of 
database information, and to ease linking with previously published resources (e.g., via 
PubMed). Protocol description should be facilitated, wherever possible, by use of standard 
templates, or reuse of existing protocols (with optional modifications). However, care must 
be taken not to lose information regarding the rationale behind a researcher’s experimental 
choices, such as study design, conditions, and protocols, as this is critically important for 
understanding. Such meta-data may not come across checklists and tables, but rather only 
through original narrative, so appropriate use of freeform text fields is essential, especially 
for protocol description. Furthermore, it is conceivable that codification of reporting might 
promote adoption of preset patterns that could impact imagination and creativity. So, a 
workable compromise must be sought, as loosely prescribed sections may encourage 
substitution of jargon, abbreviation, shorthand, and ambiguously terse description for a full 
explanation. Related to this is the worry that, as a secondary source implemented in an 
online database, MICEE data will be subject to errors, omissions, and misrepresentations 
that would not occur with peer-reviewed publication. Peer-reviewed publications are not free 
of inaccuracies themselves, of course, and the only truly reliable source is the ‘original’ – 
the investigator who performed the studies. Discrepancies between peer-review and MICEE 
reporting would be minimised by explicitly linking publication of papers and database sets. 
Curation of the MICEE database will remain a critical issue (experience with other 
repositories, for instance the CellML model repository, has shown that only verified entries 
tend to be reliable sources), especially for studies without an associated publication, and a 
mechanism for report checking will need to be developed. These are all areas where it will 
be useful to adopt technologies already under development or in use by the MIBBI 
community.
CONCLUSION
The time is ripe for open-access sharing of published data in the cardiac electrophysiology 
community. The field would benefit from Minimum Information Standards and reporting 
guidelines. Successful efforts in other research areas have hinged on general acceptance of, 
Quinn et al. Page 9
Prog Biophys Mol Biol. Author manuscript; available in PMC 2012 April 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
and compliance to, such reporting standards. Cardiac experimental electrophysiology does 
not currently have a well-defined Minimum Information Standard, and as a step toward 
establishing this, we propose the Minimum Information about a Cardiac Electrophysiology 
Experiment (MICEE; see the draft presented in Appendix A, for consideration and 
development by the greater community). A considered user interface is hoped to make 
compliance as pain-free as possible, and we hope that with time this approach will manifest 
itself as an improvement over current practice. As an initial test of its utility, during 2012, 
the authors of this communication will adhere to the then identified standard, and we invite 
the reader to join this effort, by evaluating and implementing the Minimum Information 
about a Cardiac Electrophysiology Experiment standard.
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APPENDIX A. Proposed Minimum Information Standard: Minimum 
Information about a Cardiac Electrophysiology Experiment (MICEE)
1. Material
1.1 Type (Human/Whole Animal/Isolated Heart/Isolated Tissue/Isolated 
Cells/Cell Fragments/Engineered Tissue/Cultured Cells/Stem Cells)
1.2 Ethical approval
1.3 Human
1.3.1 Gender
1.3.2 Age/developmental stage/body mass index
1.3.3 Clinical information/disease background 
(health status/known pathology/drug 
treatment/etc.)
1.3.4 Genetic variation
1.3.5 Familial history/pedigree
1.3.6 Point within circadian cycle/point within 
hormonal cycle
1.3.7 Conscious/sedated/anesthetised (agent(s)/
supplier(s)/etc.)/open/closed chest/acute/
chronic intervention
1.4 Whole Animal/Isolated Heart/Isolated Tissue/Isolated Cells/Cell 
Fragments
1.4.1 Gender
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1.4.2 Age/developmental stage/weight
1.4.3 Genus/species/strain
1.4.4 Supplier
1.4.5 Genetic variation (type/means)
1.4.6 Disease model/state (type/means/assessment)
1.4.7 Husbandry (diet/housing type/environmental 
enrichment/day-night cycle/etc.)
1.4.8 Point within circadian cycle/point within 
hormonal cycle
1.4.9 Conscious/sedated/anesthetised (agent(s)/
supplier(s)/etc.)/open/closed chest/acute/
chronic intervention
1.4.10 Method of animal dispatch
1.4.11 Anatomical origin of sample
1.4.12 Isolation procedure
1.4.13 Time and method to final preparation 
(temperature/solution/electrical/mechanical 
stimulation/mode of storage/etc.)
1.4.14 Isolated heart mode of operation (working or 
Langendorff/constant pressure or flow/
balloon/etc.)
1.4.15 Cell selection process/single cell 
confirmation/morphological status before/
during recordings
1.5 Engineered Tissue
1.5.1 Cellular/acellular composition
1.5.2 Growth conditions (time/temperature/
medium/substrate/structure/bioreactor/
supplements/electrical/mechanical 
stimulation/mode of storage/etc.)
1.6 Cultured Cells
1.6.1 Cell line
1.6.2 Source/anatomical origin of sample
1.6.3 Passage (number/conditions/density/etc.)
1.6.4 Culture conditions (time/temperature/
medium/gas/substrate/structure/supplements/
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electrical/mechanical stimulation/mode of 
storage/etc.)
1.6.5 Cell selection process/single cell 
confirmation/morphological status before/
during recordings
1.7 Stem Cells
1.7.1 Source/anatomical origin of sample
1.7.2 Passage (number/conditions/density/etc.)
1.7.3 Culture/differentiating conditions (time/
temperature/medium/gas/substrate/structure/
supplements/electrical/mechanical 
stimulation/mode of storage/etc.)
1.7.4 Cell selection process/single cell 
confirmation/morphological status before/
during recordings
2. Environment
2.1 Sample temperature
2.2 Gas partial pressures
2.3 Solution (composition/buffer/pH/osmolarity/etc.)
2.4 Flow rates
2.5 Bath volume
2.6 Chemicals/dyes/drugs (concentration(s)/supplier(s)/solvent(s)/etc.)
3. Protocols
3.1 Study design (randomisation/blinding/subject/preparation inclusion/
exclusion criteria/number of subjects/preparations/number of 
rejected subjects/preparations/number of subject/preparation 
replacements/etc.)
3.2 Sufficiently detailed account of procedures and interventions for 
offsite reproduction of study by providing time resolved protocols 
(indication of intervention/recording timings/recordings of baseline/
intervention/washout/etc.)
4. Recordings
4.1 Time window of recording
4.2 Spatial location of recording
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4.3 Electrical Recordings
4.3.1 Equipment (electrodes/pre-amplifiers/
amplifiers/recorders/etc.)
4.3.2 A/D conversion (sampling rate/channels/bit 
depth/gain/dynamic range/etc.)
4.4 Optical Measurements
4.4.1 Equipment (optical mapping system/
microscope/light sources/filters/lenses/lens 
numerical aperture/detector specifications/
etc.)
4.4.2 Settings (pinhole/gain/offset/spatial and 
temporal sampling/scan modes/etc.)
4.5 Other Recordings
4.5.1 Equipment (probes/pre-amplifiers/amplifiers/
recorders/etc.)
4.5.2 A/D conversion (sampling rate/channels/bit 
depth/gain/dynamic range/etc.)
4.6 Timing control (for multiple recording systems/stimulation/
recording/imaging etc.)
4.7 Hardware based data processing (filtering/smoothing/binning/etc.)
4.8 Software environment (operating system/acquisition program 
version/supplier/etc.)
5. Analysis
5.1 Software environment (operating system/program version/supplier/
etc.)
5.2 n number(s) (number of preparations/observations/number of 
preparations/observations per subject/etc.)
5.3 Observations inclusion/exclusion criteria/number of rejected 
observations
5.4 Signal-to-noise (method of calculation/etc.)
5.5 Software based data processing (filtering/smoothing/binning/
averaging/background signal removal/normalisation/interpolation/
extrapolation/deconvolution/etc.)
5.6 Calculated parameters (QT-interval/QRS duration/endocardial 
activation/conduction velocity/action potential duration to specified 
level of repolarisation/peak current/etc.)
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5.7 Sufficiently detailed description of statistical methods for offsite 
reproduction
5.8 Example(s) of raw and processed data (from the same recording)
APPENDIX B. Illustration of the utility of the proposed draft standard by 
application to a previously published study
Green text represents information available in the publication (or referenced publications). 
Amber text represents information that was recorded at the time of the study and is available 
upon request, but not made publically available. Unavailable indicates information that was 
either not recorded at the time of the study or is unavailable to the current authors, hindering 
post-assessment. Categories which do not apply to the present study have been excluded. 
Both Amber and Red text highlight the need for a Minimum Information Standard.
Iribe, G., Ward, C. W., Camelliti, P., Bollensdorff, C., Mason, F., Burton, R. A., Garny, A., 
Morphew, M. K., Hoenger, A., Lederer, W. J. and Kohl, P. (2009)
 Axial stretch of rat single 
ventricular cardiomyocytes causes an acute and transient increase in Ca2+ spark rate. Circ 
Res 104, 787–95.
1. Material
1.1 Type (Human/Whole Animal/Isolated Heart/Isolated Tissue/Isolated 
Cells/Cell Fragments/Engineered Tissue/Cultured Cells/Stem Cells)
• Isolated Cells
1.2 Ethical approval
• Experiments conducted in accordance with the guidelines of 
relevant institutional animal care and ethics regulations and 
in agreement with the UK Home Office Animals (Scientific 
Procedures) Act of 1986
1.4 Whole Animal/Isolated Heart/Isolated Tissue/Isolated Cells/Cell 
Fragments
1.4.1 Gender
• Unavailable
1.4.2 Age/developmental stage/weight
• Unavailable
1.4.3 Genus/species/strain
• Unavailable
1.4.4 Supplier
• Unavailable
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1.4.7 Husbandry (diet/housing type/environmental 
enrichment/day-night cycle/etc.)
• Unavailable
1.4.8 Point within circadian cycle/point within 
hormonal cycle
• Unavailable
1.4.10 Method of animal dispatch
• Terminally anesthetised by 
pentobarbital injection (100 mg/kg)
1.4.11 Anatomical origin of sample
• Ventricle
1.4.12 Isolation procedure
• Enzymatic dissociation (at ~37°C), as 
described in Mitra, R. and Morad, M. 
(1985) A uniform enzymatic method 
for dissociation of myocytes from 
hearts and stomachs of vertebrates. Am 
J Physiol 249, H1056–60.
1.4.13 Time and method to final preparation 
(temperature/solution/electrical/mechanical 
stimulation/mode of storage/etc.)
• Time: 20 minutes for enzymatic 
dissociation/Temperature: room 
temperature (~22°C)/Solution: normal 
Tyrode
1.4.15 Cell selection process/single cell 
confirmation/morphological status before/
during recordings
• Unavailable
2. Environment
2.1 Sample temperature
• Unavailable
2.2 Gas partial pressures
• Unavailable
2.3 Solution (composition/buffer/pH/osmolarity/etc.)
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a. Enzymatic dissociation solution A: Composition (in 
mmol/L): NaCl 135, KCl 5.4, MgCl2 1, NaH2PO4 0.33, 
NaOH/Buffer: 10 mmol/L HEPES/pH: Tolerance = 7.4±0.2/
Osmolarity: Tolerance = 300±10 mOsm/L
b. Enzymatic dissociation solution B: Composition: 50 mg 
collagenase I + 7 mg protease XIV in 25 mL enzymatic 
dissociation solution A/Buffer: Same as solution A/pH: Same 
as solution A/Osmolarity: Same as solution A
c. Enzymatic dissociation solution C: Composition (in 
mmol/L): Enzymatic dissociation solution A + CaCl2/Buffer: 
Same as solution A/pH: Same as solution A/Osmolarity: 
Same as solution A
d. Normal Tyrode solution: Composition (in mmol/L): NaCl 
140, KCl 10, CaCl2 1.8, MgCl2 1, glucose 11/Buffer: 5 
mmol/L HEPES/pH: Tolerance = 7.4±0.2/Osmolarity: 
Tolerance = 300±10 mOsm/L
e. Na+/Ca2+-free solution: Composition (in mmol/L): LiCl 140, 
KCl 10, EGTA 10, MgCl2 1, glucose 11/Buffer: 5 mmol/L 
HEPES/pH: Tolerance = 7.4±0.2/Osmolarity: Tolerance = 
300±10 mOsm/L
f. Fixation solution: Composition: PBS containing 2% 
glutaraldehyde
g. Post-fixation solution: Composition: 1% OsO4
2.5 Bath volume
• IonOptix Microscope Chamber <0.5 mL
2.6 Chemicals/dyes/drugs (concentration(s)/supplier(s)/solvent(s)/etc.)
a. Stretch-activated ion channel blocker: Grammostola spatulata 
mechanotoxin-4/Concentration: 2 μmol/L/Supplier: Peptide 
Institute, Osaka, Japan/Solvent: Double distilled H2O
b. Intracellular calcium indicator: Fluo-4-acetoxymethyl-ester/
Concentration: 5 μmol/L/Supplier: Invitrogen, Carlsbad, CA/
Solvent: Dimethyl sulfoxide
c. Nitric oxide synthase inhibitor: NG-nitro-L-arginine methyl 
ester/Concentration: 1 mmol/L/Supplier: Sigma-Aldrich, St. 
Louis, USA/Solvent: Double distilled H2O
d. Microtubule polymerisation inhibitor: Colchicine/
Concentration: 10 μmol/L/Supplier: Sigma-Aldrich, St. 
Louis, USA/Solvent: Double distilled H2O
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3. Protocols
3.1 Study design (randomisation/blinding/subject/preparation inclusion/
exclusion criteria/number of subjects/preparations/number of 
rejected subjects/preparations/number of subject/preparation 
replacements/etc.)
• Non-randomised/Non-blinded
3.2 Sufficiently detailed account of procedures and interventions for 
offsite reproduction of study by providing time resolved protocols 
(indication of intervention/recording timings/recordings of baseline/
intervention/washout/etc.)
a. Axial Stretch:
• Pair of carbon fibres attached to single isolated 
cardiomyocyte using two 3-axis miniature hydraulic 
manipulators (SM-28, Narishige, Tokyo, Japan), each 
mounted on separate computer-controlled 
piezoelectric translators (PZT; P-621.1CL, Physik 
Instrumente, Karlsruhe/Palmbach, Germany) of a 
custom-made railing system (IonOptix, Milton, USA)
• Axial stretch applied by piezoelectric translators 
movement of carbon fibres, graded to cause an 
increase in sarcomere length of ~8% in the stretched 
portion of the cell
• Sarcomere length changes confirmed via fast Fourier 
transformation of striation patterns in confocal images
b. Whole-Cell Stretch:
• Carbon fibres attached to each cell end
• Ca2+ spark rate compared during 5-second intervals, 
before application of stretch, immediately after onset 
of stretch, and at end of 1 minute of stretch
c. Half-Cell Stretch:
• One carbon fibre attached to centre of cell and other 
attached to one end of same cell
• Central carbon fibre remained stationary, with end-
standing carbon fibre used to apply stretch to half of 
cell, leaving remainder of cell relatively undisturbed
• Ca2+ sparks counted in both stretched and the non-
stretched portion of cell, for 5 seconds, immediately 
before and after application of stretch, and percentage 
change in Ca2+ spark rate (“during stretch” divided by 
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“pre-stretch” times 100) assessed separately for each 
cell half
d. Ca2+ Spark Measurements:
• Cells loaded with Fluo-4 by 10 minutes of incubation
• Excitation with 488 nm argon ion laser beam
• Emitted fluorescence detected above 505 nm
• XY confocal time series images acquired every 20 to 
30 ms
e. Electron Microscopy and Tomography:
• Adult rat ventricular cardiomyocytes fixed for 40 
minutes and post-fixed for 10 minutes
• Fixed cells dehydrated in acetone and embedded in 
Epon-Araldite resin (Electron Microscopy Sciences, 
Hatfield, USA)
• Sections (250 nm) cut and transferred onto electron 
tomography grids
• Colloidal gold particles (15 nm) added to both 
surfaces of sections as fiducial markers
• Electron tomograms of preparations acquired
4. Recordings
4.1 Time window of recording
• As soon as possible after preparation, up to 6 hours
4.2 Spatial location of recording
• Entire cell area
4.4 Optical Measurements
4.4.1 Equipment (optical mapping system/
microscope/light sources/filters/lenses/lens 
numerical aperture/etc.)
• LSM 510 confocal microscope (Carl 
Zeiss MicroImaging GmbH, Jena, 
Germany) for XY time series image 
acquisition
• LSM 5-Live microscope (Carl Zeiss 
MicroImaging GmbH, Jena, Germany) 
for fast XY time series image 
acquisition
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• Tecnai TF30 microscope (FEI 
Company, Eindhoven, The 
Netherlands), with images captured on 
an Ultrascan 4K CCD camera 
(GATAN Inc, Pleasanton, USA), for 
electron tomography image acquisition
4.4.2 Settings (pinhole/gain/offset/spatial and 
temporal sampling/scan modes/etc.)
• LSM 5-Live microscope: 512×30 pixel 
frame captured every 1.5 to 2.5 ms 
during half-cell stretch protocol
• Tecnai TF30 microscope: At 300 kV
• Ultrascan 4K CCD camera: Nominal 
magnification of ×23,000, projected 
image dimension of 1.02×1.02 nm2/
pixel, physical Nyquist XY resolution 
of 2.04 nm, physical Z resolution 
affected by highest possible tilt angle α 
(αmax) and cannot exceed [XY 
resolution] × [sin(αmax)]−1, effective 
resolution ~4–5 nm
4.8 Software environment (operating system/acquisition program 
version/supplier/etc.)
• LSM confocal microscope XY time series image acquisition: 
Operating system: Windows XP/Acquisition program: 
Unavailable
• Tecnai microscope and Ultrascan camera tomography image 
acquisition: Operating system: Unavailable/IMOD software 
(SerialEM, version Unavailable, available from the Boulder 
Laboratory for 3-D Electron Microscopy of Cells; http://
bio3d.colorado.edu/imod/)
5. Analysis
5.1 Software environment (operating system/program version/supplier/
etc.)
• Custom routines for Ca2+ spark measurements written in 
Interactive Data Language version 6.2 (available from 
Christopher W. Ward; ward@son.umaryland.edu) and in 
Delphi (by Alan Garny; alan.garny@dpag.ox.ac.uk)
Quinn et al. Page 23
Prog Biophys Mol Biol. Author manuscript; available in PMC 2012 April 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
• IMOD software for electron tomogram generation (eTOMO) 
and to generate 3D models of relevant structures (3dmod) 
(version Unavailable, available from the Boulder Laboratory 
for 3-D Electron Microscopy of Cells; http://
bio3d.colorado.edu/imod/)
• GraphPad Prism 4 for statistical analysis (GraphPad 
Software, La Jolla, USA)
5.2 n number(s) (number of preparations/observations/number of 
preparations/observations per subject/etc.)
• Unavailable
5.3 Observations inclusion/exclusion criteria/number of rejected 
observations
• Carbon fibre detachment
• Mechanical induction of Ca2+ waves
• Absence of background Ca2+ sparks
5.4 Signal-to-noise (method of calculation/etc.)
• Unavailable
5.5 Software based data processing (filtering/smoothing/binning/
averaging/background signal removal/normalisation/interpolation/
extrapolation/deconvolution/etc.)
a. Ca2+ Spark Measurements:
• Five-frame running average applied for each time 
point of XY time series
• 4×4 boxcar filter applied to each image
• Area containing cardiomyocyte identified as region 
with intensity 1.5 standard deviations greater than the 
background fluorescence
• Potential spark locations identified as contiguous pixel 
regions with intensity 2 standard deviations greater 
than the cardiomyocyte mean intensity
• ΔF representation of each image constructed as local 
fluorescence intensity minus net fluorescence in 
cardiomyocyte area outside potential spark locations
• Ca2+ sparks confirmed as contiguous pixel regions 
with intensity 3.8 standard deviations greater than the 
cardiomyocyte mean intensity outside potential spark 
locations
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• Ca2+ spark rate was calculated by analyzing Ca2+ 
spark frequency, with duplicate spark counts at any 
coordinate (those that lasted throughout more than one 
of the contiguous frames) subtracted
• XY regions from fast XY time series images 
containing individual sparks collapsed onto x-axis to 
provide 1D signal intensity line (pseudo line-scan 
image)
• All 1D pseudo line-scan traces stacked in 
chronological order to create 2D X time sequence 
(pseudo line-scan time plot)
• Time course of signal at centre line used to analyze 
spark amplitude, time to peak, and decay time constant 
of the spark
b. Electron Microscopy and Tomography:
• Images from each electron tomography tilt-series 
aligned (by fiducial marker tracking) and back-
projected to generate 2 single full-thickness 
reconstructed volumes (tomograms), which were 
combined to generate single high-resolution 3D 
reconstruction of original partial cell volume
• Microtubules modelled as tubes with diameter of 24 
nm and sarcoplasmic reticulum and T-tubular 
membranes modelled by contours along the bilayer 
projection delimiting distinct compartments, manually 
traced for each tomographic slice
• Model was smoothed (details Unavailable) and 
meshed (details Unavailable) to obtain final 3D 
representation, where spatial relationships among 
microtubules, sarcoplasmic reticulum, and T-tubules 
were analyzed
5.6 Calculated parameters (QT-interval/QRS duration/endocardial 
activation/conduction velocity/action potential duration to specified 
level of repolarisation/peak current/etc.)
• Sarcomere length (measured via fast Fourier transformation 
of striation patterns in confocal images)/time to Ca2+ peak/
spark amplitude (ΔF/Fo)/decay time constant/spark rate
5.7 Sufficiently detailed description of statistical methods for offsite 
reproduction
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• Paired Student’s t-test and 2-way ANOVA (where 
appropriate) with a probability value of less than 0.05 
considered to indicate significant difference between means
5.8 Example(s) of raw and processed data (from the same recording)
• Will be provided in the online repository, once established, at 
http://www.micee.org/
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